Startseite

Aktien

Cytokinetics

Nachrichten

Cytokinetics Aktie

Aktie

ISIN: US23282W6057 WKN: A1W1KK SYM: CYTK Land Flagge US

USA

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

60,77

USD

+0,75 %

+0,46 USD

Letzter Kurs 02:00:00 Nasdaq

Cytokinetics Aktie kaufen

Geldkurs

11.12.25

60,75

USD

700 STK

Briefkurs

11.12.25

60,77

USD

3.700 STK

Verkauf

Kauf

Hinweis
Verlängerte Handelszeiten
Ab sofort von 07:30 bis 23:00 Uhr

Neueste Nachrichten

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) 18.11.25 · globenewswire · Cytokinetics
CYTK LAWSUIT ALERT: Levi & Korsinsky Notifies Cytokinetics, Incorporated Investors - Lead Plaintiff Deadline November 17, 2025 17.11.25 · newsfile · Cytokinetics
CYTK DEADLINE: ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action - CYTK 17.11.25 · newsfile · Cytokinetics
CYTK FINAL DEADLINE: Faruqi & Faruqi, LLP Announces that Cytokinetics Investors Have Opportunity to Lead Class Action Lawsuit 17.11.25 · Business Wire (engl.) · Cytokinetics
Cytokinetics Supports American Heart Association Initiative to Improve Care for People Living With Hypertrophic Cardiomyopathy 17.11.25 · globenewswire · Cytokinetics
CYTK DEADLINE: ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action - CYTK 16.11.25 · newsfile · Cytokinetics
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics 16.11.25 · newsfile · Cytokinetics
Cytokinetics 72 Hour Deadline Alert: Former Louisiana Attorney General And Kahn Swick & Foti, LLC Remind Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK 15.11.25 · Business Wire (engl.) · Cytokinetics
ROSEN, A LONGSTANDING LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action - CYTK 14.11.25 · newsfile · Cytokinetics
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics 14.11.25 · newsfile · Cytokinetics
Deadline Soon: Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit 13.11.25 · Business Wire (engl.) · Cytokinetics
Securities Lawsuit Alert: Cytokinetics, Incorporated (CYTK) Investors - Contact Levi & Korsinsky Before November 17, 2025 13.11.25 · newsfile · Cytokinetics

1
2
3
4
5
…
14

CYTK DEADLINE: ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure ... 204 Leser
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ... 196 Leser
ROSEN, A LONGSTANDING LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before ... 180 Leser
Cytokinetics 72 Hour Deadline Alert: Former Louisiana Attorney General And Kahn Swick & Foti, LLC Remind Investors With Losses In Excess ... 156 Leser
CYTK DEADLINE: ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Cytokinetics, Inc. Investors to ... 124 Leser
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cytokinetics, Incorporated ... 116 Leser
Securities Lawsuit Alert: Cytokinetics, Incorporated (CYTK) Investors - Contact Levi & Korsinsky ... 116 Leser
Deadline Soon: Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Urged To Contact The Law Offices of ... 116 Leser
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics 116 Leser
CYTK FINAL DEADLINE: Faruqi & Faruqi, LLP Announces that Cytokinetics Investors Have Opportunity to Lead Class Action ... 116 Leser

Insider-Trades: Directors' Dealings – Die wichtigsten Transaktionen - KW 28/25 2064 Leser
DAX, Cytokinetics & Co. – Tops & Flops der Community am Nachmittag 1120 Leser
Borussia Dortmund, Cytokinetics & Co. – Tops & Flops der Community am Morgen 708 Leser
Cytokinetics Names Robert E. Landry to Board of Directors 224 Leser
CYTK DEADLINE: ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure ... 204 Leser
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ... 196 Leser
Cytokinetics Announces 2025 Corporate Milestones and Vision 2030 188 Leser
Cytokinetics Announces Start of AMBER-HFpEF, a Phase 2 Clinical Trial of CK-586 in Patients With ... 188 Leser
ROSEN, A LONGSTANDING LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before ... 180 Leser
Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology ... 172 Leser